Currently holds a position at aTyr Pharma Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Chief Medical Officer | aTyr Pharma Inc | Nov. 1, 2017 - |
Chief Medical Officer | aTyr Pharma Inc | March 30, 2016 - Nov. 1, 2017 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-12-12 | 2023-12-12 |
aTyr Pharma Inc
(LIFE)
|
B Purchase |
12,000
+12.7%
1.1814,136 USD |
12,000 +12.7% | 1.18 | 14,136 USD | |
2023-12-12 | 2023-12-11 |
aTyr Pharma Inc
(LIFE)
|
B Purchase |
3,000
+3.3%
1.173,510 USD |
3,000 +3.3% | 1.17 | 3,510 USD | |
2022-11-21 | 2022-11-21 |
aTyr Pharma Inc
(LIFE)
|
B Purchase |
10,000
+24.5%
2.1421,405 USD |
10,000 +24.5% | 2.14 | 21,405 USD | |
2022-07-06 | 2022-07-01 |
aTyr Pharma Inc
(LIFE)
|
B Purchase |
15,000
+58.1%
2.8843,164 USD |
15,000 +58.1% | 2.88 | 43,164 USD | |
2022-01-10 | 2022-01-07 |
aTyr Pharma Inc
(LIFE)
|
B Purchase |
5,000
+24.0%
6.7633,807 USD |
5,000 +24.0% | 6.76 | 33,807 USD | |
2021-11-15 | 2021-11-15 |
aTyr Pharma Inc
(LIFE)
|
B Purchase |
2,500
+13.7%
8.5821,438 USD |
2,500 +13.7% | 8.58 | 21,438 USD | |
2021-05-20 | 2021-05-18 |
aTyr Pharma Inc
(LIFE)
|
B Purchase |
10,000
+120.5%
4.0140,100 USD |
10,000 +120.5% | 4.01 | 40,100 USD | |
2021-02-09 | 2021-02-09 |
aTyr Pharma Inc
(LIFE)
|
S Sale |
778
-8.6%
7.665,959 USD |
778 -8.6% | 7.66 | 5,959 USD | |
2020-06-23 | 2020-06-19 |
aTyr Pharma Inc
(LIFE)
|
B Purchase |
6,000
+464.8%
4.2725,620 USD |
6,000 +464.8% | 4.27 | 25,620 USD | |
2020-02-07 | 2020-02-07 |
aTyr Pharma Inc
(LIFE)
|
S Sale |
745
-36.6%
4.033,002 USD |
745 -36.6% | 4.03 | 3,002 USD |